Diversified Trust Co. Increases Position in HCA Healthcare, Inc. $HCA

Diversified Trust Co. grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 9.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,885 shares of the company’s stock after purchasing an additional 1,405 shares during the quarter. Diversified Trust Co.’s holdings in HCA Healthcare were worth $7,883,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC acquired a new stake in shares of HCA Healthcare in the 4th quarter worth $1,021,000. NewEdge Advisors LLC increased its position in HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after purchasing an additional 409 shares during the last quarter. Sivia Capital Partners LLC boosted its holdings in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares during the last quarter. MAI Capital Management increased its holdings in shares of HCA Healthcare by 9.7% during the 2nd quarter. MAI Capital Management now owns 2,832 shares of the company’s stock worth $1,085,000 after buying an additional 251 shares during the last quarter. Finally, Journey Strategic Wealth LLC acquired a new position in HCA Healthcare in the second quarter valued at approximately $250,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $494.97 on Tuesday. The stock’s 50-day moving average is $510.42 and its two-hundred day moving average is $474.60. The company has a market cap of $110.66 billion, a price-to-earnings ratio of 17.44, a price-to-earnings-growth ratio of 1.52 and a beta of 1.34. HCA Healthcare, Inc. has a 1-year low of $314.43 and a 1-year high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same period in the previous year, the company posted $6.22 earnings per share. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 annualized dividend and a yield of 0.6%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio is presently 10.99%.

Analysts Set New Price Targets

HCA has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft lifted their target price on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Wells Fargo & Company raised their price objective on HCA Healthcare from $452.00 to $481.00 and gave the stock an “equal weight” rating in a research report on Friday, January 30th. JPMorgan Chase & Co. increased their target price on shares of HCA Healthcare from $420.00 to $535.00 and gave the stock a “neutral” rating in a research note on Friday, February 20th. Barclays boosted their price target on shares of HCA Healthcare from $494.00 to $551.00 and gave the company an “overweight” rating in a research note on Wednesday, January 28th. Finally, TD Cowen lifted their target price on shares of HCA Healthcare from $529.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, March 10th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $537.73.

Insider Activity

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the business’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president owned 8,853 shares in the company, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the sale, the executive vice president owned 30,003 shares in the company, valued at approximately $14,944,194.27. This trade represents a 4.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 15,214 shares of company stock worth $7,797,595 over the last quarter. Insiders own 1.50% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.